Found: 40
Select item for more details and to access through your institution.
Comparison of the tolerability of <sup>161</sup>Tb- and <sup>177</sup>Lu-labeled somatostatin analogues in the preclinical setting.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 13, p. 4049, doi. 10.1007/s00259-024-06827-2
- By:
- Publication type:
- Article
Synthesis and Preclinical Evaluation of Radiolabeled [ 103 Ru]BOLD-100.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 11, p. 2626, doi. 10.3390/pharmaceutics15112626
- By:
- Publication type:
- Article
Simultaneous Visualization of 161 Tb- and 177 Lu-Labeled Somatostatin Analogues Using Dual-Isotope SPECT Imaging.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 4, p. 536, doi. 10.3390/pharmaceutics13040536
- By:
- Publication type:
- Article
Combination of Proton Therapy and Radionuclide Therapy in Mice: Preclinical Pilot Study at the Paul Scherrer Institute.
- Published in:
- Pharmaceutics, 2019, v. 11, n. 9, p. 450, doi. 10.3390/pharmaceutics11090450
- By:
- Publication type:
- Article
Therapeutic Potential of 47Sc in Comparison to 177Lu and 90Y: Preclinical Investigations.
- Published in:
- Pharmaceutics, 2019, v. 11, n. 8, p. 424, doi. 10.3390/pharmaceutics11080424
- By:
- Publication type:
- Article
Highlight selection of radiochemistry and radiopharmacy developments by editorial board.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2021, v. 6, n. 1, p. 1, doi. 10.1186/s41181-021-00146-9
- By:
- Publication type:
- Article
A tool for nuclear imaging of the SARS-CoV-2 entry receptor: molecular model and preclinical development of ACE2-selective radiopeptides.
- Published in:
- EJNMMI Research, 2023, v. 13, n. 1, p. 1, doi. 10.1186/s13550-023-00979-2
- By:
- Publication type:
- Article
In Vivo Imaging of Local Inflammation: Monitoring LPS-Induced CD80/CD86 Upregulation by PET.
- Published in:
- Molecular Imaging & Biology, 2021, v. 23, n. 2, p. 196, doi. 10.1007/s11307-020-01543-3
- By:
- Publication type:
- Article
Active bone marrow S-values for the low-energy electron emitter terbium-161 compared to S-values for lutetium-177 and yttrium-90.
- Published in:
- EJNMMI Physics, 2022, v. 9, n. 1, p. 1, doi. 10.1186/s40658-022-00495-7
- By:
- Publication type:
- Article
Precise activity measurements of medical radionuclides using an ionization chamber: a case study with Terbium-161.
- Published in:
- EJNMMI Physics, 2022, v. 9, n. 1, p. 1, doi. 10.1186/s40658-022-00448-0
- By:
- Publication type:
- Article
New Radionuclides and Technological Advances in SPECT and PET Scanners.
- Published in:
- Cancers, 2021, v. 13, n. 24, p. 6183, doi. 10.3390/cancers13246183
- By:
- Publication type:
- Article
Dosimetric Analysis of the Short-Ranged Particle Emitter 161 Tb for Radionuclide Therapy of Metastatic Prostate Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 9, p. 2011, doi. 10.3390/cancers13092011
- By:
- Publication type:
- Article
Activity Measurement of 44 Sc and Calibration of Activity Measurement Instruments on Production Sites and Clinics.
- Published in:
- Molecules, 2023, v. 28, n. 3, p. 1345, doi. 10.3390/molecules28031345
- By:
- Publication type:
- Article
Chelation of Theranostic Copper Radioisotopes with S-Rich Macrocycles: From Radiolabelling of Copper-64 to In Vivo Investigation.
- Published in:
- Molecules, 2022, v. 27, n. 13, p. 4158, doi. 10.3390/molecules27134158
- By:
- Publication type:
- Article
Terbium sisters: current development status and upscaling opportunities.
- Published in:
- Frontiers in Nuclear Medicine, 2024, p. 1, doi. 10.3389/fnume.2024.1472500
- By:
- Publication type:
- Article
Comparison of the dosimetry of scandium-43 and scandium-44 patient organ doses in relation to commonly used gallium-68 for imaging neuroendocrine tumours.
- Published in:
- EJNMMI Physics, 2024, v. 11, n. 1, p. 1, doi. 10.1186/s40658-024-00669-5
- By:
- Publication type:
- Article
Alpha-PET for Prostate Cancer: Preclinical investigation using <sup>149</sup>Tb-PSMA-617.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-54150-w
- By:
- Publication type:
- Article
Preclinical investigations and first-in-human application of <sup>152</sup>Tb-PSMA-617 for PET/CT imaging of prostate cancer.
- Published in:
- EJNMMI Research, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1186/s13550-019-0538-1
- By:
- Publication type:
- Article
Internal radiation dosimetry of a <sup>152</sup>Tb-labeled antibody in tumor-bearing mice.
- Published in:
- EJNMMI Research, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1186/s13550-019-0524-7
- By:
- Publication type:
- Article
Preclinical Evaluation of Gastrin-Releasing Peptide Receptor Antagonists Labeled with <sup>161</sup>Tb and <sup>177</sup>Lu: A Comparative Study.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 3, p. 481, doi. 10.2967/jnumed.123.266233
- By:
- Publication type:
- Article
Albumin-Binding and Conventional PSMA Ligands in Combination with <sup>161</sup>Tb: Biodistribution, Dosimetry, and Preclinical Therapy.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 10, p. 1625, doi. 10.2967/jnumed.123.265524
- By:
- Publication type:
- Article
<sup>161</sup>Tb-DOTATOC Production Using a Fully Automated Disposable Cassette System: A First Step Toward the Introduction of <sup>161</sup>Tb into the Clinic.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 7, p. 1138, doi. 10.2967/jnumed.122.265268
- By:
- Publication type:
- Article
First-in-Human Application of Terbium-161: A Feasibility Study Using <sup>161</sup>Tb-DOTATOC.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.258376
- By:
- Publication type:
- Article
First-in-Human Application of Terbium-161: A Feasibility Study Using <sup>161</sup>Tb-DOTATOC.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.258376
- By:
- Publication type:
- Article
First-in-Human Application of Terbium-161: A Feasibility Study Using <sup>161</sup>Tb-DOTATOC.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.258376
- By:
- Publication type:
- Article
First-in-Human Application of Terbium-161: A Feasibility Study Using <sup>161</sup>Tb-DOTATOC.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.258376
- By:
- Publication type:
- Article
First-in-Human Application of Terbium-161: A Feasibility Study Using <sup>161</sup>Tb-DOTATOC.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.258376
- By:
- Publication type:
- Article
First-in-Human Application of Terbium-161: A Feasibility Study Using <sup>161</sup>Tb-DOTATOC.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 1, doi. 10.2967/jnumed.120.258376
- By:
- Publication type:
- Article
First-in-Human Application of Terbium-161: A Feasibility Study Using <sup>161</sup>Tb-DOTATOC.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 5, p. 1, doi. 10.2967/jnumed.120.258376
- By:
- Publication type:
- Article
First-in-Human Application of Terbium-161: A Feasibility Study Using <sup>161</sup>Tb-DOTATOC.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 3, p. 1, doi. 10.2967/jnumed.120.258376
- By:
- Publication type:
- Article
Therapeutic Radiometals Beyond <sup>177</sup>Lu and <sup>90</sup>Y: Production and Application of Promising α-Particle, β<sup>—</sup>-Particle, and Auger Electron Emitters.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, p. 91S, doi. 10.2967/jnumed.116.186825
- By:
- Publication type:
- Article
Fifty Shades of Scandium: Comparative Study of PET Capabilities Using Sc-43 and Sc-44 with Respect to Conventional Clinical Radionuclides.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 10, p. 1826, doi. 10.3390/diagnostics11101826
- By:
- Publication type:
- Article
Developments toward the Implementation of 44 Sc Production at a Medical Cyclotron.
- Published in:
- Molecules, 2020, v. 25, n. 20, p. 4706, doi. 10.3390/molecules25204706
- By:
- Publication type:
- Article
A Step-by-Step Guide for the Novel Radiometal Production for Medical Applications: Case Studies with 68Ga, 44Sc, 177Lu and 161Tb.
- Published in:
- Molecules, 2020, v. 25, n. 4, p. 966, doi. 10.3390/molecules25040966
- By:
- Publication type:
- Article
Production and characterization of no-carrier-added <sup>161</sup>Tb as an alternative to the clinically-applied <sup>177</sup>Lu for radionuclide therapy.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2019, v. 4, n. 1, p. N.PAG, doi. 10.1186/s41181-019-0063-6
- By:
- Publication type:
- Article
<sup>44</sup>Sc for labeling of DOTA- and NODAGA-functionalized peptides: preclinical in vitro and in vivo investigations.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2016, p. 1, doi. 10.1186/s41181-016-0013-5
- By:
- Publication type:
- Article
First-in-human administration of terbium-161-labelled somatostatin receptor subtype 2 antagonist ([<sup>161</sup>Tb]Tb-DOTA-LM3) in a patient with a metastatic neuroendocrine tumour of the ileum.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 8, p. 2517, doi. 10.1007/s00259-024-06641-w
- By:
- Publication type:
- Article
Opportunities and potential challenges of using terbium-161 for targeted radionuclide therapy in clinics.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 11, p. 3181, doi. 10.1007/s00259-023-06316-y
- By:
- Publication type:
- Article
Combination of terbium-161 with somatostatin receptor antagonists—a potential paradigm shift for the treatment of neuroendocrine neoplasms.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 4, p. 1113, doi. 10.1007/s00259-021-05564-0
- By:
- Publication type:
- Article
Terbium-161 for PSMA-targeted radionuclide therapy of prostate cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 9, p. 1919, doi. 10.1007/s00259-019-04345-0
- By:
- Publication type:
- Article